
ABSTRACT Background Androgenetic alopecia (AGA) is a progressive hair disorder characterized by follicular miniaturization and gradual reductions in hair density and hair shaft diameter. Platelet‐rich plasma (PRP) has emerged as a regenerative therapeutic modality for AGA. Experimental literature suggests that physical conditioning may influence platelet activation and the release of platelet‐derived mediators. However, whether combined red‐light and low‐temperature conditioning of PRP provides additional clinical benefit in AGA has not been investigated. This study therefore compared photo‐ and temperature‐conditioned platelet‐rich plasma (PTC‐PRP), prepared using red‐light exposure under low‐temperature conditions, with conventional PRP (C‐PRP) in patients with AGA. Methods This split‐scalp, double‐blind randomized active‐comparator trial enrolled 21 adults with mild‐to‐moderate AGA. Each participant received four intradermal treatment sessions at 4‐week intervals. One randomized scalp side received PTC‐PRP, while the contralateral side received C‐PRP. Trichoscopic assessments were performed at baseline and Weeks 4, 8, 12, 16, and 24. Outcomes included hair density, non‐vellus hair density, and non‐vellus hair diameter. Pain scores and adverse events were recorded. Results Longitudinal improvements from baseline were observed for several trichoscopic outcomes on both treatment sides. However, treatment‐by‐time interactions were not significant for hair density ( p = 0.966), non‐vellus hair density ( p = 0.869), or non‐vellus hair diameter ( p = 0.627). Post hoc baseline‐adjusted comparisons, three‐way treatment‐by‐time‐by‐sex interactions, and sensitivity analyses excluding two stable topical‐minoxidil users were also nonsignificant. No serious adverse events were observed, and both treatments were well tolerated. Conclusion Both C‐PRP and PTC‐PRP were associated with increases in hair shaft diameter over 24 weeks, while improvements in hair density were modest and variable. No statistically significant efficacy or tolerability difference was detected between PTC‐PRP and C‐PRP.
ABSTRACT Background Keratosis pilaris (KP) is a common, benign, hereditary primary follicular keratotic condition. A variety of topical and laser therapies have been employed for its treatment with varying degrees of efficacy. Objective The primary outcome was to compare the effectiveness and safety of 755 nm long‐pulsed alexandrite laser versus fractional CO 2 laser in KP treatment in skin of color, and the secondary outcome was establishing some KP grading systems. Patients and Methods Forty female patients with KP were randomly allocated into two treatment groups. A 755 nm long‐pulsed alexandrite laser was used to treat Group A, while Group B received treatment with a fractional carbon dioxide laser. Each patient received four consecutive treatment sessions at 4‐week intervals. Results Significant clinical and dermoscopic improvement was observed in both groups. There was a statistically significant difference at 12 weeks follow‐up in the mean total KPAI in both Group A ( p < 0.001) and in Group B ( p < 0.001). Comparison between both groups, the results were statistically significant ( p < 0.001) with better response in Group A treated by long‐pulsed alexandrite laser. Significantly higher patient satisfaction was in Group A ( p = 0.016). Recurrence rate in Group A was significantly lower ( p < 0.001) at 12‐weeks follow up assessment. Conclusions Both the 755‐nm long‐pulsed alexandrite laser and fractional CO 2 laser demonstrated promising clinical improvement and acceptable tolerability in KP treatment in skin of color patients. The Long‐pulsed alexandrite laser showed higher patient satisfaction and a lower recurrence rate in this study. Larger multicenter studies with longer follow‐up are required to confirm these findings.